Pfizer is a US-based multinational pharmaceutical company founded in 1849, headquartered in New York City.
Is this your business? Add your evidence →
Pfizer discloses robust climate data with GHG Protocol alignment and SBTi validation, but progress is dire: only 15% of its 46% emissions reduction target achieved by 2024, renewable energy stuck at 14% despite RE100 membership, and hazardous waste flat since 2022. Critically, Pfizer's climate messaging is undermined by active membership in trade associations (US Chamber, NAM) that lobby against climate policy.
Pfizer scores 39/100 (Below expectations) on SINK's independent climate assessment, scored from public data only. Fees pay for the review, never the result. Last verified May 2026.
That places Pfizer joint 385th of 847 companies scored, and joint 11th of 19 in Healthcare / Pharmaceuticals.
Where Pfizer sits among healthcare / pharmaceuticals peers.
Among the 19 major healthcare / pharmaceuticals brands we've scored, Pfizer is tied =11th of 19, with 3 others.
Its three lowest-scoring questions, and what the evidence didn't show.
Despite RE100 membership and 100% renewable electricity target by 2030, Pfizer sourced only 14% renewable electricity in 2024, up marginally from 10% in 2023.
References nature in sustainable medicines and green chemistry but lacks TNFD-aligned disclosure, quantified nature footprint, and deforestation-free commitment.
Scope 1&2 emissions fell 15% from 2019 to 2024 (1.27 to ~1.06 MtCO₂e); total emissions declined 14.19% year-on-year 2023–2024.
A score changes when the evidence does. We use new published evidence at the next rescore. Evidence that isn't public can count through an evidence review.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Add your evidence, £99
Scored low because little is published? Send us your evidence. A person reviews it and your score reflects what you really do. Done within 5 working days.
Evidence review →Go tender-ready, £495 a year
A yearly rescore, a check of up to 25 key suppliers and a score badge for your website (coming soon).
Get in touch →Strongest on Carbon Footprint — Operations and Transparency & Accountability (7/10, 7/10). Weakest on Energy Source and Nature & Biodiversity Impact (3/10, 3/10).
The 3 companies in the sector scoring nearest above Pfizer.
AbbVie has achieved meaningful absolute emissions reductions and maintains science-aligned near-term climate targets, but obscures its full supply chain footprint and lacks net-zero validation.
See the breakdown →Philips demonstrates strong climate governance with SBTi-validated targets, 80% renewable energy, and A-list CDP scores across 11 years.
See the breakdown →The formula and all 12 sources.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale12 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
8 of 12 sources are independent of the company.
If you believe a source has been misread or a newer version exists, submit a challenge.
Pfizer is a US-based multinational pharmaceutical company founded in 1849, headquartered in New York City. With 78,500 employees and $63.6 billion in annual revenue, it ranks among the world's largest drug manufacturers. Pfizer develops vaccines, oncology treatments, primary care medicines, and specialty healthcare products across multiple therapeutic areas.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
See what's behind your number →Fees pay for the review, never the result.